CORC

在结果中检索

CORC

浏览/检索结果: 共89条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
Oral pH Values Predict the Incidence of Radiotherapy Related Caries in Nasopharyngeal Carcinoma Patients 会议论文
作者:  Li, Z.;  Wu, Q.;  Meng, X.;  Jiang, D.;  Yu, H.
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Advanced cyberinfrastructure for agricultural drought monitoring 会议论文
作者:  Sun, Ziheng;  Di, Liping;  Fang, Hui;  Guo, Liying;  Yu, Eugene
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05
Calculation and control of DC bias current distribution in an AC power system around a typical ±800 kV DC grounding electrode 会议论文
作者:  Wu, Fangjie;  Yu, Shifeng;  Zhao, Zheng;  Quan, Wanlin
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 会议论文
作者:  Ning, F.;  Li, X.;  Yu, L.;  Zhang, B.;  Zhao, Y.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 会议论文
作者:  Ning, F.;  Li, X.;  Yu, L.;  Zhang, B.;  Zhao, Y.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Oral pH Values Predict the Incidence of Radiotherapy Related Caries in Nasopharyngeal Carcinoma Patients 会议论文
作者:  Li, Z.;  Wu, Q.;  Meng, X.;  Jiang, D.;  Yu, H.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace